Enliven Therapeutics (ELVN) Property, Plant & Equipment (Net) Growth (1y) (2020 - 2026)
Enliven Therapeutics (ELVN) Property, Plant & Equipment (Net) Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 58.66% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | -10.19% |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 2.65% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 24.11% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 12.18% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | -95.71% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Enliven Therapeutics | 3.33 Bn | 2.88 Bn | - | -95.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -95.05% |
| Dec 31, 2025 | -92.58% |
| Sep 30, 2025 | -27.32% |
| Jun 30, 2025 | -26.67% |
| Mar 31, 2025 | -40.85% |
| Dec 31, 2024 | -38.27% |
| Sep 30, 2024 | -31.89% |
| Jun 30, 2024 | -27.34% |
| Mar 31, 2024 | -19.93% |
| Dec 31, 2023 | -16.63% |
| Jun 30, 2023 | 725.71% |
| Mar 31, 2023 | 45.07% |
| Dec 31, 2022 | 256.00% |
| Jun 30, 2022 | -64.88% |
| Mar 31, 2022 | 81.48% |
| Dec 31, 2021 | -28.37% |
| Sep 30, 2021 | -26.86% |
| Jun 30, 2021 | -25.25% |
| Mar 31, 2021 | -22.49% |
| Dec 31, 2020 | -21.04% |